- Home
- ASMB vs FNGR Comparison
ASMB vs FNGR Comparison
Compare ASMB & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASMB
- FNGR
- Stock Information
- Founded
- ASMB 2005
- FNGR 2016
- Country
- ASMB United States
- FNGR Singapore
- Employees
- ASMB N/A
- FNGR N/A
- Industry
- ASMB Biotechnology: Pharmaceutical Preparations
- FNGR Computer Software: Prepackaged Software
- Sector
- ASMB Health Care
- FNGR Technology
- Exchange
- ASMB Nasdaq
- FNGR Nasdaq
- Market Cap
- ASMB 84.5M
- FNGR 72.0M
- IPO Year
- ASMB 2010
- FNGR N/A
- Fundamental
- Price
- ASMB $10.03
- FNGR $1.49
- Analyst Decision
- ASMB Strong Buy
- FNGR
- Analyst Count
- ASMB 3
- FNGR 0
- Target Price
- ASMB $33.00
- FNGR N/A
- AVG Volume (30 Days)
- ASMB 37.9K
- FNGR 209.5K
- Earning Date
- ASMB 05-07-2025
- FNGR 05-28-2025
- Dividend Yield
- ASMB N/A
- FNGR N/A
- EPS Growth
- ASMB N/A
- FNGR N/A
- EPS
- ASMB N/A
- FNGR N/A
- Revenue
- ASMB $28,520,000.00
- FNGR $33,570,107.00
- Revenue This Year
- ASMB $10.82
- FNGR $260.03
- Revenue Next Year
- ASMB N/A
- FNGR N/A
- P/E Ratio
- ASMB N/A
- FNGR N/A
- Revenue Growth
- ASMB 298.16
- FNGR N/A
- 52 Week Low
- ASMB $7.75
- FNGR $1.03
- 52 Week High
- ASMB $19.93
- FNGR $3.96
- Technical
- Relative Strength Index (RSI)
- ASMB 48.99
- FNGR 57.17
- Support Level
- ASMB $7.90
- FNGR $1.25
- Resistance Level
- ASMB $10.36
- FNGR $1.36
- Average True Range (ATR)
- ASMB 0.85
- FNGR 0.11
- MACD
- ASMB 0.21
- FNGR -0.01
- Stochastic Oscillator
- ASMB 86.04
- FNGR 96.52
About ASMB Assembly Biosciences Inc.
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.